Abstract:Background: Cognitive impairment has long challenged the patients with major depressive disorder (MDD), hypocretins and inflammation have recently been implicated in cognitive function. However, limited studies have compressively assessed their associations with cognitive impairment in MDD. Methods: A total of 100 MDD patients and 100 healthy controls (HC) were recruited for this study. They were tested with HAMD, HAMA, and MCCB scales. The plasma level of selected inflammatory factors (IL-1 beta, IL-6, and TNF-alpha) and hypocretin-1 were determined using enzyme-linked immunosorbent assay (ELISA). Correlation analysis was performed to explore the relationship between the plasma level of the factors and clinical performances. Results: Patients with MDD showed cognitive impairment in each MCCB subdomain except working memory compared with HC. The levels of IL-6, IL-1 beta and hypocretin-1 in MDD patients were higher than HC. Besides, IL-1 beta levels was negatively correlated with overall cognitive function in the combined group. Hypocretin-1 was positively correlated with socially cognitive impairment in MDD patients. A negative correlation between plasma hypocretin-1 levels and HAMA scales was also observed in MDD patients. Limitation: The study was cross-sectional, thereby limiting causal inference, and had a relatively small sample size. There are no subcategories for MDD based on characteristics. Conclusion: IL-1 beta, IL-6 and Hypocretin-1 were reported as potential factors involved in MDD pathology. Hypocretin-1 could contribute to the biological mechanisms of anxiety relief. Hypocretin-1, therefore, may be important in exploring the pathological mechanisms of social cognitive impairment in MDD patients. Conclusively, this study provides new insights for exploring cognitive impairment in depression.

Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol.

Immunoendocrine Aspects of Major Depression

Relationships Between Interleukin-6 Activity, Acute Phase Proteins, and Function of the Hypothalamic-Pituitary-adrenal Axis in Severe Depression.

Linking peripheral IL-6, IL-1 and hypocretin-1 with cognitive impairment from major depression

Increased Plasma Concentrations of Interleukin-6, Soluble Interleukin-6, Soluble Interleukin-2 and Transferrin Receptor in Major Depression.

Plasma Soluble Interleukin-2-receptor in Depression: Relationships to Plasma Neopterin and Serum IL-2 Concentrations and HPA-axis Activity

Interleukin-1-Beta - A Putative Mediator of Hpa Axis Hyperactivity in Major Depression

Plasma-soluble Interleukin-2 and Transferrin Receptor in Schizoprenia and Major Depression

Increased Serum Interleukin-1-receptor-antagonist Concentrations in Major Depression

Immune Disturbances During Major Depression: Upregulated Expression of Interleukin-2 Receptors

Increased Serum IL-6 and IL-1 Receptor Antagonist Concentrations in Major Depression and Treatment Resistant Depression.

A Further Exploration of the Relationships Between Immune Parameters and the Hpa-Axis Activity in Depressed-Patients

Plasma Levels of Interleukin-6, Interleukin-10, and Interleukin-1 Receptor Antagonist in Depression: Comparison Between the Acute State and after Remission

Indicators of Immune Activation in Major Depression.

Serotonin-Immune Interactions in Major Depression

Immune Disturbances in Severely Depressed Patients: Relationship with Cortisol Secretion.

Depression‐related Disturbances in Mitogen‐induced Lymphocyte Responses and Interleukin‐1β and Soluble Interleukin‐2 Receptor Production

Increased Neopterin and Interferon-Gamma Secretion and Lower Availability of L-tryptophan in Major Depression: Further Evidence for an Immune Response

Multiple Reciprocal Relationships Betweenin Vivocellular Immunity and Hypothalamic–pituitary–adrenal Axis in Depression

Psychoimmune Investigation in Obsessive-Compulsive Disorder - Assays of Plasma Transferrin, Il-2 and Il-6 Receptor, and Il-1-Beta and Il-6 Concentrations

Depression, Traumatic Stress and Interleukin-6